GENE ONLINE|News &
Opinion
Blog

Postpartum Depression
Feature Novo NordiskChikungunya
GeneOnline’s Weekly News Highlights: Aug 7-11
2023-08-14
Innovation Postpartum Depressionmental health
ZURZUVAE™: A Ray of Hope for Women with Postpartum Depression
2023-08-09
Trials & Approvals Major Depressive Disorder
NDA for Biogen-Sage’s Zuranolone Accepted by FDA, Marking Another Step Forward in Depression Drug Development
2023-02-07
Trials & Approvals Depression
Biogen, Sage Pursue 2022 Filing for Depression Therapy, Zuranolone
2021-10-20
M&A
With Hopes to Lead CRO Industry, Thermo Fisher Bids $17.4 Billion on Latest Acquisition
2021-04-15
R&D Depression
Biogen and Sage Therapeutics Ink Deal for Treating Depression
2020-11-29
Ranking & Reports CRISPR
GeneOnline’s Top Ten Headlines of the Year
2019-12-30
Trials & Approvals Anxiety
FDA Approves New Drug for Specific Treatment of Postpartum Depression
2019-03-21
LATEST
Ginkgo Bioworks and Pfizer Forge $331 Million Collaboration for RNA-Based Drug Discovery
2023-09-29
Johnson & Johnson Partners with Singapore to Boost Life Sciences Innovation
2023-09-28
Vietnam and South Korea Strengthen Cooperation in Multiple Sectors
2023-09-27
PeptiDream and Genentech Collaborate on Novel Peptide-Radioisotope Drug Conjugates
2023-09-27
AcuraStem and Takeda Collaborate on Innovative ALS Treatment
2023-09-27
Seven AI/ML for Life Sciences Companies Identified as Innovators in New Clarivate Companies to Watch Report
2023-09-27
GeneOnline’s Weekly News Highlights: Sept 17-Sept 22
2023-09-26
READ MORE
EVENT
2023-10-04
BioFuture 2023
New York city,USA
2023-11-16
3rd INTERNATIONAL CONFERENCE ON NUTRITION AND HEALTHCARE
Dubai, UAE
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2023 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top